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ABSTRACT Amyloid ﬁbrils are often found arranged into large ordered spheroid structures, known as spherulites, occurring in
vivo and in vitro. The spherulites are predominantly composed of radially ordered amyloid ﬁbrils, which self-assemble from
protein in solution. We have observed and measured amyloid spherulites forming from heat-treated solutions of bovine insulin at
low pH. The spherulites form in large numbers as semispherical dome-shaped objects on the cell surfaces, showing that
surface defects or impurities, or the substrates themselves, can provide good nucleation sites for their formation. Using optical
microscopy, we have measured the growth of individual spherulites as a function of time and in various conditions. There is a lag
time before nucleation of the spherulites. Once they have nucleated, they grow, each with a radius increasing linearly, or faster
than linearly, with time. Remarkably, this growth period has a sudden end, at which all spherulites in the system suddenly stop
growing. A model of spherulite formation based on the polymerization of oriented ﬁbrils around a nucleus, from a precursor in
solution, quantitatively accounts for the observed growth kinetics. Seeding of native insulin solutions with preformed spherulites
led to the preformed spherulites growing without a lag time. This seeding behavior is evidence that the ﬁbrils in the spherulites
assemble from small protein species rather than ﬁbrils. The density of the spherulites was also measured and found to be
constant with respect to radius, indicating that the space ﬁlls as the spherulite grows.
INTRODUCTION
A wide range of proteins is known to misfold and aggregate
in mildly denaturing conditions into large polymeric struc-
tures known as amyloid ﬁbrils. These ﬁbrils are found in a
range of degenerative diseases, such as Alzheimer’s disease,
Parkinson’s disease, type II diabetes, prion diseases, senile
systemic amyloidosis, and Huntingdon’s disease. The ﬁbrils
can also be formed in vitro, from proteins associated with
a disease, as well as proteins associated with none (1).
Amyloid ﬁbrils have been found to be based on a common
structure, consisting of continuous intermolecular b-sheets
which run along the ﬁbril axis, such that the individual
b-strands are perpendicular to the ﬁbril axis (2). This common
structural motif, based only on the peptide backbone, as well
as the observation that a wide variety of proteins forms these
ﬁbrils, suggests that amyloid ﬁbrils are a generic form of
protein assembly structure (3). The ﬁbrils tend to be long
(.1 mm) and unbranched, with diameters typically between
6 and 12 nm (4).
In the different amyloid diseases, the ﬁbrils are deposited
in various forms. In a form identiﬁed in Alzheimer’s disease
and Downs’ syndrome, they are found in birefringent spher-
ical plaques (5). The birefringence of the plaques shows that
the material of which they are composed is anisotropic, and
ordered in a spherically symmetric way. In some diseases,
amyloid deposits occur in vast quantities but it is still gen-
erally unknown what role, if any, the ﬁbrils and plaques may
have in each disease.
Large spherical ordered assemblies of amyloid ﬁbrils have
been observed in several other systems in vivo and in vitro
(6–20), and are described by various names. Here we term
them spherulites, by analogy to the similar, ordered structures
formed by crystallizing polymers (21–23).
Bovine insulin is a small protein whose ability to form
ﬁbrillar structures and spherulites has been known for almost
60 years (7). The ﬁbrils are characterized by the same fea-
tures as other amyloid ﬁbrils (24,25). Some details of the
molecular structure have been determined, using data from
cryoelectron microscopy (26). Each ﬁbril contains a number
of protoﬁlaments twisted together, each protoﬁlament being
a linear chain of insulin molecules (26). The spherulites have
been found to be structurally similar to the wide range of
amyloid spherulite structures described above (6,27,28).
Krebs et al. (6,27) suggested that the spherulites are
composed of amyloid ﬁbrils that grow outwards from a core,
which may be a protein aggregate without amyloid structure.
Spherulite cores could be observed that were in contrast with
the surrounding material because of their lack of directional
order and lack of afﬁnity to amyloid-speciﬁc dyes (6). Com-
paring the onset of spherulite formation and the formation
of ﬁbrils dispersed in the solution led to evidence that the
growing spherulites do not assemble from the dispersed
ﬁbrils, but more likely from a small precursor species—either
insulin monomers or small oligomers in solution. Therefore,
assembly of proteins into spherulites may proceed along
a separate (though not necessarily dissimilar) pathway to
assembly of proteins into dispersed ﬁbrils. Insulin spher-
ulites are formed in large quantities in solutions of bovine
insulin, at pH 2 or lower, while under prolonged heating at
temperatures of 65C or higher. Under these conditions,
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a high proportion (;90–95%) of insulin is converted to
spherulites and dispersed ﬁbrils, with the remainder in the
form of insulin monomers or small oligomers (6). Therefore,
it seems that the reaction of insulin to form spherulites and
ﬁbrils is limited by depletion of the precursor.
In this article, we observe bovine insulin spherulites form-
ing on cell surfaces using differential interference contrast
(DIC) contrast optical microscopy. The resulting timelapse
video images are used to track the growth of individual
spherulites with time, in various conditions. These measure-
ments of growth are complemented with other images and
measurements to provide insights into the structure, forma-
tion mechanism, and growth kinetics of the spherulites. We
propose a growth model, limited by the rates of ﬁbril elon-
gation and precursor diffusion to account for our measure-
ments. Seeding of native insulin solutions with preformed
spherulites and other nucleation effects are also observed.
EXPERIMENTAL PROCEDURES
Sample preparation
Bovine insulin and all other chemicals were of analytical grade or better, and
were obtained from Sigma-Aldrich, Gillingham, UK and used without
further puriﬁcation. Insulin solutions of concentration 5.0 mg/ml were made
by weighing the dry powder and dissolving in Milli-Q deionized water
adjusted to pH 1.50 with HCl (Millipore, Billerica, MA). The insulin
solutions were then readjusted to pH 1.50 with concentrated HCl. These
solutions were ﬁltered with a 0.45-mmMillipore protein ﬁlter to remove dust
and aggregated or undissolved protein, after which they were vacuum-
degassed. They were then put into glass cavity slides and sealed with cov-
erslips. These slides and coverslips had been previously cleaned with
concentrated hydrochloric/nitric acids to remove any traces of organic resi-
dues on their surfaces. In experiments where samples were compared under
different conditions, the same insulin stock solution was used for each to
ensure that the pH, insulin concentration, and trace impurities were the same
for all samples.
Polystyrene-coated surfaces were also used for some experiments: a
cavity slide and coverslip were solution-coated with polystyrene by dipping
in a polystyrene/toluene solution and allowing to dry.
Optical microscopy of spherulite formation
Each sample was placed on a Linkam hot-stage set to temperatures of 65–
75C under a Zeiss Axioplan optical microscope (Carl Zeiss, Welwyn
Garden City, UK) in DIC mode, at 1003 magniﬁcation. The microscope
was focused on the lower surface of the cell to view the spherulites which
form immobilized on the surface. Digital images were taken, and timelapse
videos composed. Distances in the image plane were calibrated by imaging
a 100-mm scale bar, resulting in a resolution of 1.295 mm/pixel.
Measurement of spherulite sizes
Since most spherulites have an approximately circular shape on the
micrographs, a radius of each could be measured. Spherulites which were
out-of-focus or deviated signiﬁcantly from a circular shape, especially where
two or more spherulites were joined together, were excluded. For each
spherulite, the radius was measured from a manually chosen center, to the
outside edge, deﬁned by its sharp increase in brightness on the DIC images.
A MatLab (The MathWorks, Natick, MA) script was written to ﬁnd this
edge. Due to the irregularities in the shape of the spherulites, a typical radial
error of 65 mm is estimated.
Laser scanning confocal microscopy
Confocal microscopy allowed vertical cross-sectional images to be made of
spherulites bound to a surface. A Zeiss LSM510 confocal microscope was
used (Carl Zeiss). A coverslip coated with insulin spherulites was submerged
in a solution of the amyloid-speciﬁc dye, thioﬂavin-T, of concentration
0.1 mg/ml at pH 1.5, and sealed with a cavity slide. An optical magniﬁcation
of 5003 and pinhole size of 50 mm were used. The dye was excited with the
458-nm line of an Argon ion laser. By scanning through the spherulite in
three dimensions, cross-sections of the spherulite could be captured.
Seeding of insulin solutions with
preformed spherulites
An insulin solution of concentration 5.0 mg/ml at pH 1.5 was prepared as in
Sample Preparation, above, and heated at 70C in an Eppendorf tube for
2 h, forming many unattached spherulites. These spherulites were rinsed as
follows: a small amount (200 ml) of the solution containing spherulites was
transferred to a dilute HCl solution at pH 1.5 (1 ml), stirred and mildly
centrifuged to sediment the spherulites. The excess HCl solution was
decanted and replaced with a fresh pH 1.5 HCl solution.
Ten-microliter aliquots of the rinsed spherulite solution, containing small
numbers of preformed spherulites, were added to fresh solutions of insulin of
variable concentration 0.2–5.0 mg/ml, at pH 1.5, in cavity slide cells. Each
sample was heated at 70C (as in Optical Microscopy of Spherulite For-
mation, above) to measure the growth of the preformed spherulites in fresh
insulin solutions.
Spherulite density measurements
An insulin solution, prepared as described above, was heated at 70C for 2 h
in an Eppendorf tube. The unattached spherulites were separated from the
solution by mild centrifugation, rinsed and transferred to a solution of HCl in
a rectangular cuvette cell with the same ionic conditions as those in which
they were prepared (pH 1.5). The cuvette was mounted vertically and
imaged with the telecentric zoom microscope of an FTA200 system (First
Ten Angtroms, Portsmouth, VA), at maximum magniﬁcation. Videos of the
spherulites falling through the solution were captured, to measure the radius
and sedimentation velocity of each spherulite. The spherulite density as
a function of radius was calculated from these measurements.
RESULTS
A solution of insulin was prepared and heated in a glass
cavity slide at 70C for 2 h. Inspection of the sample showed
a large number of spherulites had formed, which were easily
visible with optical microscopy. The spherulites can be seen
using DIC contrast or by putting the sample between crossed
polarizers, as in Fig. 1 a, where each spherulite shows a
distinctive Maltese-cross extinction pattern. By scanning up
and down through the sample, it could be seen that many
spherulites were attached to the lower and upper surfaces of
the cell, but relatively few situated between. This observation
was made in all our experiments, except when we seeded the
solution with preformed spherulites or left the insulin solu-
tion unﬁltered. In these cases, unattached spherulites could
be seen to drift slowly across the ﬁeld of view as they
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formed. It is evident that in our preparation conditions, there
is a lack of spherulite nucleation sites in bulk solution com-
pared to the surfaces, so the surfaces are where nucleation
predominantly occurs. This may be because of the nature of
the substrate itself, or because of surface impurities or defects.
Using confocal microscopy, we imaged cross-sections of
spherulites formed on the cell surface, using the ﬂuorescent
amyloid-speciﬁc dye, thioﬂavin-T. Fig. 1 b shows resulting
orthogonal sections of a spherulite. The spherulites have a
dumbbell-like appearance due to the anisotropic orientation
of the dye molecules, which bind to the ﬁbrils, radially ar-
ranged in the spherulite (5,6). Each spherulite has a core to
which thioﬂavin-T does not bind. Each core can be seen in
contact with the surface of the cell (Fig. 1 b), suggesting that
it forms or attaches itself there before the spherulite grows
around it. The spherulites could also be viewed from the side
by careful mounting of their glass substrate in the optical
microscope. Fig. 1 c shows a horizontal perspective of a
surface-bound spherulite, at a slight angle of elevation. In
this image, taken with DIC contrast, the spherulite core is
also visible. As seen in Fig. 1, b and c, the spherulites seem to
form a dome shape, intermediate between a hemisphere and
a full sphere.
The surface spherulites are immobilized while they grow,
and therefore they present us with an opportunity to measure
the growth of each individually. A sample of insulin was
prepared and heated at 75C, and imaged every 2 min by
DIC contrast optical microscopy. A small section of each
snapshot is shown in Fig. 2 a, and the full video is included
in the online supplement to this article (Supplementary
Material, Video Suppl. 1). Spherulites appeared after 20 min
and grew to diameters of;100mm, as can be seen in Fig. 2 a.
After 42 min, the spherulites have stopped growing. The
ﬁnal image at 68 min is taken again with the sample between
crossed polarizers, and shows the characteristic Maltese crosses
of the spherulites. The spherulites nucleate at different times
and reach a steady-state radius. They are polydisperse at all
times.
The complete image of this sample at 68 min is shown in
Fig. 2 b. Circles are plotted to show the measured radii of all
spherulites in focus on that image. A subset of the spherulites
in the image was sampled to include the full range of sizes
observed (Fig. 3, inset). The radii r(t), of the spherulites as
a function of heating time t, were measured in each snapshot.
Spherulites of r  5 mm and smaller appear very dim and
diffuse, mainly due to the limitations of our optics, so radii of
these values are excluded. A graph of radius against time is
shown for this sample (Fig. 3).
The experiment was repeated at temperatures of 65C and
70C, and the results are shown in Fig. 4 a. As temperature is
increased, the lag time before the appearance of spherulites
decreases and the spherulites reach a ﬁnal radius sooner.
Looking at Figs. 3 and 4 a, some remarkable features can
be noted. Firstly, there is a long lag-time before the appear-
ance of any spherulites, but once a few appear, many more
appear within a short time. Each spherulite grows steadily
after its ﬁrst appearance, with radius increasing linearly, or
slightly faster than linearly, with time. The growth of each
spherulite comes to a sudden stop, at a steady-state radius
R, rather than slowing down gradually.
We may plot these curves in another way to emphasize the
features of the growth: in Fig. 4 b, r(t) – R is plotted so that
each curve is superposed after growth ends. This plot shows
FIGURE 1 Optical microscopy of insulin spherulites attached to a surface.
(a) DIC contrast (left) and optical rotation images (right) of the same area
(with 100-mm scale bar). Out-of-focus blobs are spherulites on opposite
surface. (b) Confocal microscopy: orthogonal sections (50-mm scale bar).
Solid lines deﬁne sections; arrows show surface of substrate; shading shows
regions of saturated ﬂuorescence intensity. (c) Horizontal view with DIC
contrast (50-mm scale bar). Arrow shows the core region.
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that the sudden end of the growth occurs for all spherulites in
each sample at approximately the same halt-time tR. Halt-
times of 108, 68, and 42 min are measured at 65C, 70C,
and 75C, respectively, as shown by the arrows in Fig. 4 b.
The curves have an upward curvature, which shows that the
growth accelerates as the spherulites get larger. However,
this effect seems to be fairly slight: the lines lie close to a
universal curve, as they would if growth rate was constant,
for each sample.
The growth curves can be ﬁtted in a simpliﬁed way, ac-
cording to the observed features. To the measurements of r(t)
for each spherulite, parameters of nucleation time tN, initial
growth rate ki, and steady-state radius R, can be ﬁtted.
Our procedure was to deﬁne:
1. The steady-state radius R, of a spherulite, as the average
of all points of radii satisfying jr(t) – r(tF)j# 4 mm, where
tF is the time of the last captured frame.
2. The initial growth rate ki, of a spherulite, as the average
increase of radius per unit time between the ﬁrst recorded
radius and R/4.
3. The nucleation time tN, of a spherulite, by linearly extrapo-
lating the initial growth rate to zero radius.
Fig. 5 a shows one result from the sample at 75C. All
measured spherulites were ﬁtted according to this procedure,
and the ﬁtted lines of radius against time show a reasonable
ﬁt to the measured curves (see Fig. 5 b). For all sampled
spherulites at each temperature, we plot R, ki, and tN against
FIGURE 2 Sample of insulin spherulites at 75C,
imaged with DIC contrast. The microscope is focused on
the lower surface of the cell. The out-of-focus spherulites
are mostly attached to the upper surface. (a) Time-lapse
frames from 0 to 68 min, arranged in order from left to
right, and top to bottom, showing a small section of the
complete image (shown in b). A 100-mm scale bar is
shown (bottom right). (b) Spherulites after 68 min. As
shown, the radii of all spherulites in focus have been
measured (solid circles). A 200-mm scale bar is shown.
FIGURE 3 Radius measurements as a function of time for spherulites at
75C. (Inset) Measured subset of the complete sample.
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each other to explore correlations between their values. The
results are shown in Fig. 6. Fig. 6, a and c, show a clear
separation in tN for different temperatures. However, in each
sample, there is a large spread of ki, which seems to be un-
correlated with both R and tN, and does not change notice-
ably with increasing temperature (Fig. 6, b and c). However,
R is clearly correlated with tN for all temperatures, conﬁrm-
ing that the growth is steady once the spherulites have
nucleated (Fig. 6 a). We have ﬁtted the plots of R against tN
with linear least-squares ﬁts (Fig. 6 a), yielding correlation
coefﬁcients of 0.86, 0.83, and 0.94 at 65C, 70C, and 75C,
respectively (see (29), Section 14.5). These ﬁts are in the
form corresponding to constant linear growth of the spher-
ulites in a sample:
R ¼ kðtN  tRÞ; (1)
where k, the average growth rate between the nucleation time
and halt-time, has the values 1.50, 2.73, and 3.95 mm/min for
65C, 70C, and 75C, respectively. However, the ﬁtted
values of tR ¼ 100, 55, and 33 min, are smaller than the ob-
served halt-times of 108, 68, and 42 min for 65C, 70C, and
75C, respectively. This discrepancy reﬂects that the growth
of the spherulites is slightly accelerating over time, as no-
ticeable in Figs. 3–5.
The features of the growth have been described above
without considering the local environment of each spheru-
lite. It seems that characteristics of the local environment,
such as proximity of neighboring spherulites, have not had
an important effect on the features of the growth as identiﬁed
above, although they may have contributed to the variation
between individual spherulites.
FIGURE 4 Comparison of spherulite growth between samples at 65C,
70C, and 75C. (a) Comparison of r(t). (b) Comparison of r(t)  R. All
spherulites in each sample can be seen to stop growing at the same time: 108,
68, and 42 min, respectively, as marked by the arrows.
FIGURE 5 Fitting of spherulite growth curves with nucleation time tN,
initial growth rate ki, and steady-state radius R (ﬁtted lines are dashed). (a)
Example ﬁt: single spherulite at 75C; (b) all measured spherulites at
65–75C.
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To determine the ﬁnal size-distribution of the spherulites,
r(tF) was measured for all spherulites in focus in the ﬁnal
image of the samples at each temperature. A histogram of
these radii is plotted in Fig. 7. The size distribution is similar
at all three temperatures: the count decreases monotonically
with increasing radius for R . 20 mm. For R # 5 mm, the
spherulites are too dim to be measured. According to the
results above, the ﬁnal radius of each spherulite has an ap-
proximately linear dependence on its nucleation time. There-
fore, the size-distribution contains preserved information of
the nucleation rate as a function of time. The distributions of
Fig. 7 thus seem to indicate that this nucleation rate increases
monotonically for most or all of the growth period for each
sample presented.
The formation of large numbers of dome-shaped spher-
ulites on the cell surfaces suggest that surfaces and seeds
play an important role in the spherulite nucleation. We tried
various experiments to look for such effects.
One experiment tested the difference between cHCl/
HNO3-cleaned glass surfaces and polystyrene surfaces, as
examples of strongly hydrophilic and hydrophobic surfaces.
Two cells were prepared, ﬁlled with an insulin solution, and
heated to 70C. One cell was of cleaned glass as above, and
one was solution-coated with polystyrene. As previously,
images were taken at 2-min intervals and spherulite radii
sampled. The resulting graphs of r(t) are shown in Fig. 8. As
FIGURE 6 Correlations between nucleation time tN, initial growth rate ki,
and steady-state radius R, for spherulites formed at 65C, 70C, and 75C.
FIGURE 7 Histogram of all radii in ﬁnal frames of samples at 65C,
70C, and 75C (left to right bars, respectively).
FIGURE 8 Comparison of spherulites grown on cHCl/HNO3 cleaned
glass and polystyrene-coated glass.
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can readily be seen, there is no signiﬁcant difference in growth
rates or typical nucleation times between the samples, and
the growth period of both samples ends at approximately the
same halt-time. This experiment was repeated twice and the
same lack of difference noted.
However, a curious effect was observed, which strongly
hints at the inﬂuence of surface impurities or particles on
spherulite nucleation. We made several other samples using
glass slides and coverslips straight out of the manufacturer’s
box, without cHCl/HNO3 treatment. Fig. 9 shows spherulite
beads-on-a-string that formed at 70C on a glass coverslip
surface (Menzel, Braunschweig, Germany; part No. MNJ-
350-040B). On untreated glass, these strings appeared in
several, but not all, samples. Since this effect was never
observed on the cleaned glass, it seems likely that streaks of
some unknown impurity are responsible for this very effec-
tive spherulite nucleation. (A video of the strings growing is
included in the Supplementary Material, Video Suppl. 2.)
We also tried seeding the growth of spherulites by adding
rinsed preformed spherulites to a new solution of native in-
sulin, of concentration 5 mg/ml, again heating at 70C. As
can be seen in Fig. 10, the two preformed spherulites in the
image grew immediately and steadily, without any time delay
after the onset of heating. (A video clip of these preformed
spherulites growing is included in the Supplementary
Material, Video Suppl. 3.) Apart from the preformed spher-
ulites, new spherulites appeared at times much reduced from
the typical nucleation times detailed previously, so that it is
possible that these were nucleating on other, smaller seed par-
ticles or spherulite fragments from the preformed solution.
Using the same procedure, the growth of preformed spher-
ulites in fresh insulin solutions of variable concentration c, in
the range 0.2–5.0 mg/ml, was measured. The initial growth
rate ki of each preformed spherulite at each concentration
was determined by a linear ﬁt of the measured r(t) for times
0 # t # 6 min (not shown). In Fig. 11, ki is plotted against
c for each preformed spherulite measured. At low insulin
concentration, ki increases with c. However, at c. 1 mg/ml,
ki has no obvious dependence on c.
To better understand the structure and growth of the spher-
ulites, we measured the density of insulin spherulites with
respect to radius. An insulin solution was prepared and
heated at 70C for 2 h in an Eppendorf tube, producing many
unattached spherulites. The spherulites were then transferred
to a dilute HCl solution and the radii and sedimentation
velocities V, of 57 of them, were measured (see Spherulite
Density Measurements, above). The density of spherulites
can be calculated from the sedimentation velocity via the
Stokes drag for spherical particles, neglecting irregularities
in the spherical shape of the spherulites,
Dr ¼ 9hV
2R
2
g
; (2)
where Dr is the difference between the spherulite density
and the density of water, h ¼ 1.0 mPas, and g is the
FIGURE 9 The appearance of spherulite strings on an untreated glass sur-
face. A number of large isolated spherulites have also appeared.
FIGURE 10 Growth of new spherulites compared to preformed spher-
ulites, when added to a fresh solution of insulin and heated at 70C.
FIGURE 11 Initial growth rates ki, of preformed spherulites when ad-
ded to fresh solutions of insulin at concentrations c, and heated at 70C.
(Different markers are used at each concentration for comparison with Fig.
16, where the same data is analyzed and rescaled.)
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acceleration due to gravity. V is plotted against R in Fig. 12 for
all measured spherulites, and clearly shows the relationship:
V } R2, indicating that the density of the spherulites is
constant with respect to radius. Errors in measuring V are
small, as plotted in Fig. 12. A least-squares ﬁt of V ¼ 7.523
104 m1 s1 R2 is also plotted in Fig. 12. From the constant
of proportionality, we obtain Dr ¼ 34.5 kgm3 using Eq. 2.
However, we also note that there is a signiﬁcant variability
between sedimentation velocities of spherulites of the same
radius. This variability may be at least partially due to de-
viations from spherical of the spherulite shape, which would
directly affect the sedimentation velocity.
DISCUSSION
Shape, density, and structure
We have observed the formation of dome-shaped insulin
spherulites attached to a substrate. Microscopy of the spher-
ulites shows cores in contact with the substrate (Fig. 1, b and
c), and the spherulites extended around them. Video micros-
copy of growing spherulites shows that they are discrete
objects with a clear boundary once r has grown beyond the
limit of resolution. It therefore appears that our spherulites
have formed by nucleation of a core, and growth by the
addition of insulin from solution, in accordance with pre-
vious observations (6,27). Krebs et al. found that the core of
insulin spherulites is a non-amyloid aggregate, and the major
part of the spherulite, the corona, surrounding the core is
composed of insulin ﬁbrils aligned in the radial direction
(6,27).
Sedimentation experiments have shown that the density of
the spherulites is constant with respect to radius. This has
interesting implications for the spherulite structure and the
arrangement of ﬁbrils within. For this model of the spherulite
to satisfy the requirement of constant density (see Results,
above), the space in the corona must somehow be ﬁlled to
keep the density uniform. Any sparse structural model in
which the space does not ﬁll as the spherulite grows, would
not predict constant density of the spherulite as a function of
radius. For example, if we model the spherulite as composed
only of one-dimensional ﬁbrils growing unbranched from
a central nucleus, we would predict Dr ; R2. Similarly, a
fractal aggregate model of dimensionality d, similar to those
observed in other aggregating systems (30), would predict
Dr ; R3–d. This would be unsatisfactory unless d ¼ 3; i.e.,
the space-ﬁlling limit.
This information allows us to elaborate on the sche-
matic model of Krebs et al. (27). As the spherulite expands,
the gaps between the growing ﬁbrils must ﬁll such that the
density is kept constant. One possibility is that the ﬁbrils
branch to produce a three-dimensional structure (Fig. 13).
Another possibility is that the gaps in the spherulite ﬁll by
nucleation of ﬁbrils at the propagating interface, analogously
to the polycrystalline growth models of Granasy et al. (31).
Either of these possibilities would represent an additional
mechanism involved in the spherulite growth, although our
measurements do not yield further information on either.
In the sample we measured, the spherulites are 34.5 kgm3
denser than water. This value allows us to calculate the
number of protein molecules within the spherulite per unit
volume, nm,
Dr ¼ nmmm 1 rwater
rprotein
 !
; (3)
wheremm is the bovine insulin molecular mass of 5733.5 Da,
rprotein is the density of protein (i.e., mass of protein divided
by volume of all displaced water molecules) for which we
use the average value for crystalline protein of 0.81 Da A˚3
(32), and rwater ¼ 998 kgm3. This yields nm ¼ 1.373 1025
m3 from our measurements. Neglecting any nonﬁbrillar
protein material that the spherulite may contain, we can now
estimate the spacing of ﬁbrils within the spherulite. Jimenez
et al. (26) analyzed cryoelectron micrographs of insulin
ﬁbrils and found that each insulin molecule occupies 23 4.8
A˚ of length along each protoﬁlament, variable numbers of
FIGURE 12 Sedimentation velocity V, plotted against radius R, for
insulin spherulites, showing a relationship: V } R2. The measurement error
in V is small (plotted as vertical error bars). A least-squares ﬁt of V¼ 7.523
104 m1 s1 R2 is plotted.
FIGURE 13 Schematic models of spherulites. (a) A spherulite com-
posed of unbranched ﬁbrils growing from a central nucleus would not have
constant density with respect to radius. Rather the space within the spherulite
must ﬁll as the spherulite grows. (b) Possibilities are that the ﬁbrils branch or
nucleate on the growth front.
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which twist together to form the ﬁbrils. For ﬁbrils prepared in
similar conditions to ours, they found that only one type of
ﬁbril, composed of four protoﬁlaments, was abundant. As-
suming that the ﬁbrils in the spherulite are completely aligned
and have the same structure as those in the study of Jimenez
et al., we obtain a protoﬁbril density (number per unit area
perpendicular to the ﬁbril axis), of nm3 9.6 A˚¼ 1.33 1016m2
and ﬁbril density s ¼ nm 3 9.6 A˚/4 ¼ 3.3 3 1015 m2. The
latter corresponds to an average separation of 1=
ﬃﬃﬃ
s
p ¼ 17 nm
between aligned ﬁbrils in the spherulite. Compared to the
ﬁbril diameter of 12 nm (26), we can see that the arrange-
ment of ﬁbrils in the spherulite is fairly compact, as illus-
trated in Fig. 14.
Growth kinetics
The measurements of spherulite growth as a function of time
show some remarkable features. The spherulites nucleate at
various times, and grow at a rate that increases slightly with
increasing radius. Finally, all spherulites in the sample sud-
denly stop growing at essentially the same time. There is
some variability between growth rates of individual spher-
ulites in each sample, just as there is some variability in their
shape and density. However, this variability is relatively
modest: the growth curves show the same features and ap-
proximately the same average growth rate k, independently
of when they have nucleated, and their location with respect
to their neighbors.
These observations can be explained within the context of
the spherulite structural model discussed above, in which
spherulites are composed of amyloid ﬁbrils which nucleate
on a core, and grow by the addition of precursor units from
the solution to ﬁbril ends on the spherulite surface. The precise
form of these precursors is unknown: they could be indi-
vidual insulin monomers, whether native or in some activated
form, or oligomers and larger aggregate species.
The spherulite’s radial growth rate is then linked directly
to the elongation rate of the ﬁbrils constituting its surface. An
elongation-rate-limited polymerization reaction of precur-
sors with ﬁbril ends, where each precursor adds a constant
distance dp to the length of the ﬁbril in a rate-limiting re-
action time t, will produce a constant ﬁbril elongation rate.
This would produce a constant radial growth rate k, if the
ﬁbrils are oriented perfectly radially,
k ¼ dp
t
: (4)
If a spherulite contains n precursor units, we can model the
precursor addition rate dn=dt, per unit area of spherulite
surface, composed of ﬁbril ends of density s. If the limiting
reaction rate 1/t, of precursors joining a ﬁbril end, is lower
than the rate at which the precursors can be provided by
diffusion, the radial growth rate will be elongation-rate-
limited, following Eq. 4. In this case, the precursor addition
rate is independent of the concentration of precursors in
solution, cp:
dnelo:lim:
dt
¼ s
t
: (5)
However, if the converse is true: if the limiting reaction
rate 1/t is higher than the rate at which precursors are pro-
vided by diffusion, the precursor addition rate will vary with
cp. The extreme case is that the provision of precursors by
diffusion is much slower than 1/t, so the precursor addition
rate is diffusion-limited. In this extreme, every precursor that
reaches the spherulite sticks, and the precursor addition rate, is
dndiff:lim:
dt
¼ cpD
r
; (6)
where D is the precursor diffusivity. This expression is based
on a steady-state solution of the diffusion equation in spher-
ical coordinates, with a boundary condition of zero precursor
concentration at radius r, as appropriate for a sticky sphere of
this radius (reviewed in (33)).
If the insulin solutions are prepared with high enough
concentration, spherulite growth will follow the limiting
FIGURE 14 Spherulite density and packing. (a) The insulin ﬁbril is
composed of protoﬁlaments, each a chain of insulin monomers with repeat
distance of 9.6 A˚ (26). Assuming the spherulite is completely composed of
these ﬁbrils arranged radially (b), the spherulite density allows estimation of
the end density of ﬁbrils on the spherulite surface s ¼ 3.33 1015 m2. This
is equivalent to a 17-nm average ﬁbril separation (c).
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elongation-rate of Eq. 4. Therefore, we identify the observed
average growth rate k, with k, to compare our model with
experiment. The abrupt end of the growth can also be ac-
counted for by the model, assuming that it is caused by the
depletion of precursors from the solution. As precursors are
consumed, cp will decrease, until the growth of each spher-
ulite is no longer elongation-rate-limited. By this point, the
precursor addition rate will start to fall, eventually reaching
zero. For each spherulite, the end of the elongation-rate-limited
growth regime will occur when cp has dropped to a level
where ðdnelo:lim:=dtÞ;ðdndiff:lim:=dtÞ. The equality of these
limiting rates (Eqs. 5–6) deﬁnes a transition ratio of cp/r that
we shall call g,
g ¼ s
Dt
¼ sk
Ddp
; (7)
using Eq. 4 to substitute for t. The growth model is shown
schematically in Fig. 15. The rate at which precursors are con-
sumed is proportional to the total area of spherulite surfaces
in the sample. This area continually increases at an accelerat-
ing rate as more and more spherulites nucleate, and those
which have nucleated grow, so accordingly we can expect cp
to drop at an accelerating rate. As a result, the precursor
addition rate would drop very quickly in time from a steady
value to zero, qualitatively producing the observed growth
curves, in which the steady growth of each spherulite halts
abruptly.
Eq. 7 can be used with the measured growth rates to
compare our model with experiment. If we suppose that each
precursor is an insulin monomer, then dp¼ 9.6 A˚/4 for a four-
protoﬁlament ﬁbril, according to the results of Jimenez et al.
(26). An approximate value of D may be obtained according
to the Stokes-Einstein diffusivity equation, taking the radius
of the insulin monomer as 10.3 A˚ (the x-ray radius of gyra-
tion according to its crystal structure 2INS in the Protein
Data Bank, http://www.pdb.org). Then using s and k as
calculated from our measurements, we obtain g ¼ 2.4, 4.3,
and 6.3 mM mm1 or 0.014, 0.025, and 0.037 mg ml1 mm1
for the samples at 65C, 70C, and 75C, respectively.
We have observed steady growth of spherulites with radii
up to ;80 mm. Taking r ¼ 80 mm, we predict a qualitative
steady growth rate for concentrations of cp . 1.1, 2.0, and
2.9 mg/ml, for the samples at 65C, 70C, and 75C,
respectively. The initial insulin concentration of 5 mg/ml
satisﬁes these inequalities, so our model is consistent with
experiment at all three temperatures. In other words, the
spherulite growth in these conditions is slow enough to be
limited by the elongation-rate of ﬁbrils on the spherulite
surface, as we have described.
The kinetic model can be tested more quantitatively using
the measured initial growth rates ki of preformed spherulites
of initial radius r, growing at 70C (see Results, above). For
convenience, we take cp equal to the initial insulin concentra-
tion c, and examine this assertion later. Plotting ki against c/r
for each spherulite then allows a direct comparison with the
elongation-rate and diffusion limits, as modeled in Eqs. 4
and 5 and illustrated in Fig. 15. The result is shown in Fig.
16. The measured points show a reasonable quantitative
agreement with our model. Within the error of radius mea-
surement and the variability between individual spherulites,
ki exhibits two regimes: it increases with c/r for c/r small, and
remains constant for c/r large. The transition between the
regimes occurs at c/r  g ¼ 0.025 mg ml1 mm1 as we have
predicted, taking k ¼k¼ 2.73 mm/min as above. We
emphasize that no adjustable parameters have been used in
this comparison: the growth rate k, and ﬁbril-end density s,
were determined from other measurements in this article; the
monomer repeat distance, dp, is from the ﬁbril structural
model of Jimenez et al. (26); and the diffusivity, D, was
calculated from the monomer’s radius of gyration. Looking
again at Eq. 7, we can also see that the calculation of g is
independent of the number of protoﬁlaments per ﬁbril, since
both s and dp are inversely proportional to this number.
FIGURE 15 Schematic model of spherulite growth: as spherulites
nucleate and grow, the precursor concentration cp decreases. Each spherulite
follows the trajectory shown: the rate of precursor addition per unit area,
ðdn=dtÞ, is constant until cp/r falls to ;g.
FIGURE 16 Growth of preformed spherulites when added to fresh
solutions of insulin, heated at 70C. Initial growth rate ki is plotted against
the initial ratio of concentration to radius c/r, for each spherulite, allowing
direct comparison with the predicted growth kinetics: a elongation-rate limit
of k ¼ k ¼ 2:73 mm min1 for c/r  g ¼ 0.025 mg ml1 mm1 and
diffusion limit for c/r  g. (The different markers are used to identify
concentrations in the range 0.3 # c # 5 mg/ml, according to the scale of
Fig. 11.)
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Our assumptions that the precursor species is the insulin
monomer, and that cp equals c, must be examined. Our cal-
culation of g is approximately independent of the identity of
the precursor, since g depends on the product Ddp (Eq. 7),
and both D and dp depend on the linear dimension of the
precursor, being proportional and inversely proportional,
respectively. Our model is therefore insensitive to the actual
identity of the precursor, whether it is an insulin monomer,
an oligomer, or larger aggregate species. However, by equat-
ing the precursor concentration cp, with the insulin concen-
tration c, we have also assumed that all insulin in solution
is in its precursor form. We may tentatively examine this
assumption by comparing the measured and predicted
diffusion-limited growth rates, as c/r / 0. The measured
ki values in this region are close to, but noticeably below, the
predicted diffusion-limit (Fig. 16). This comparison suggests
that a large fraction, but not all, of the insulin in solution at
70C and pH 1.5 is in its precursor form at the onset of
heating. Therefore, the precursor is likely to be a monomeric
or small oligomeric form of insulin, and cannot be a species
which takes a signiﬁcant heating time to form. This result
supports the suggestion of Krebs et al. (6).
We noted above that the radial growth rate of each spher-
ulite was not quite constant, but tended to accelerate slightly
with time during the growth period. This observation may
have several qualitative explanations. Rather than the ﬁbrils
being perfectly radially ordered, their order of alignment may
increase as the spherulite radius increases. The branching or
ﬁlling of space between the ﬁbrils as they radially diverge
may also affect the growth rate: there will be more space to
ﬁll for a radial increment Dr, per unit surface area, at small
r than large r. Alternatively, the accelerating growth may
reﬂect some characteristic difference between the spherulite
core and corona.
Nucleation
Insulin spherulites can form as surface-bound domes as well
as suspended spheres. In our experiments, the high ratio of
surface area to volume of each cell, and the lack of nuclea-
tion sites in the ﬁltered protein solution, appear to have
favored nucleation of spherulites on the surfaces relative to
the bulk.
The seeding of insulin solutions with preformed spher-
ulites led to the preformed spherulites growing immediately
at the onset of heating, without a time delay. Therefore, it
seems that the ﬁbril ends that constitute the spherulite surface
have remained active after they stop growing due to deple-
tion of precursor, in the sense that when a spherulite is trans-
ferred to a new insulin solution, the ends can continue
growing without a time delay.
The formation of surface-bound insulin spherulites was
not affected by the simple hydropathicity of the surface.
Spherulites grown on hydrophilic glass and hydrophobic
polystyrene substrates showed no difference in nucleation
times, growth rates, or the halt-time. It should be pointed out
that this is an unexpected ﬁnding. Sluzky et al. (34) found
that agitation of an insulin solution increased the propensity
of spherulite formation, and interpreted the positive result as
being caused by the increased area of the hydrophobic air
interface. Other experimental studies have also discussed the
positive role of hydrophobic interactions on the formation of
amyloid ﬁbrils in general and insulin in particular (e.g.,
(24,35)).
The formation of strings of spherulites on untreated glass
strongly hints at the inﬂuence of surface impurities or par-
ticles on spherulite nucleation. It would be most interesting
to ﬁnd and characterize substances that can induce the for-
mation of amyloid spherulites.
CONCLUSIONS
We have observed bovine insulin spherulites forming on cell
surfaces using DIC-contrast optical microscopy, and tracked
the growth of individual spherulites with time. The density of
the spherulites and their formation under variable conditions
have also been studied to provide insights into their structure,
formation mechanism, and growth kinetics. A model of
spherulite formation based on the radial elongation of ori-
ented ﬁbrils around a nucleus, by polymerization from a
precursor in solution, where the growth is limited by the rates
of ﬁbril elongation and precursor diffusion, quantitatively
accounts for the observed growth kinetics.
Our method allows us to follow the formation of individual
amyloid spherulites immobilized on a surface, directly—thus
providing an ideal opportunity for testing the effect of sur-
faces and seeds on the formation of spherulites, as a model of
physiological amyloid plaques.
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